Who is a good candidate for TAF antiviral therapy?

Good candidates are adults with chronic hepatitis B who have detectable viral DNA and elevated liver enzymes, indicating active infection. It is also suitable for those with compensated liver disease or who have developed resistance to older antivirals like lamivudine. Contraindications include advanced kidney disease (eGFR below 15 mL/min) or known allergy to tenofovir. Pregnant women should consult a specialist, as TAF is generally considered safe but requires individual assessment.